Consumer Retailing Canadian Community

Couche-Tard is taking on its biggest deal yet by buying Poland’s Żabka Group with borrowed money, and it’s even promising not to fold the chain into its own network. At the same time, its dividend raises keep getting smaller even though the company seems to have plenty of room to pay more, raising questions about what’s really changing under the hood.Read more

Loblaw leans into healthcare services and pharmacy clinics while automating its stores and supply chain, aiming to keep shoppers coming back and cut day-to-day costs. The big question is whether it can pull off this heavy investment while online rivals and public scrutiny squeeze the grocery business.Read more

Couche-Tard leans harder into ready-to-eat food, loyalty perks, and a smoother in-store digital experience to keep customers coming back—and it’s also buying and building more locations to widen its reach. The big question is whether it can offset slipping fuel and tobacco sales while keeping costs and tougher competition from squeezing profits.Read more

Loblaw faces a tougher road ahead as more shoppers move online, discount rivals squeeze prices, and public scrutiny could hurt trust and raise costs. At the same time, its push into automation, loyalty-driven personalization, and higher-margin store brands could decide whether it protects profits or keeps losing ground.Read more

CareRx makes its money serving pharmacies inside senior homes, but tightening government healthcare budgets and shifting senior living habits could squeeze what it earns and slow demand over time. See why some analysts expect its profits to come under pressure even as facility expansion, acquisitions, and buybacks could still support the business.Read more

Metro is betting on revamped stores, faster distribution, and a bigger online footprint to keep shoppers loyal as Canadian cities grow and buying habits shift. The catch is that tighter grocery competition and rising costs could squeeze profits, especially in the regions where it’s most concentrated.Read more

CareRx could ride Canada’s push to expand long-term care, as more seniors move into facilities that need pharmacy support. But the story comes with a catch: growth leans heavily on adding more beds while drug price pressure and a tighter balance sheet could limit how much progress turns into lasting profit.Read more

Loblaw is leaning on new discount stores, stronger local supply, and a bigger role in pharmacy and clinics to keep shoppers coming back as Canada’s population ages. The big question is whether faster online competition, rising labor costs, and public trust issues around grocery prices could derail that momentum.Read more

Catalysts About CareRx CareRx is a leading provider of specialized pharmacy services to seniors living and long term care communities across Canada. What are the underlying business or industry changes driving this perspective?Read more